1.PCR is used to measure the patient's molecular response (the extent to which the BCR- ABL gene is decreased).PCR用于检测患者的分子反应（BCR-ABL基因的减少程度）。

2.Background Nilotinib has been shown to be a more potent inhibitor of BCR-ABL than imatinib.有研究表明与伊马替尼相比，尼罗替尼是一种更强效的BCR-ABL抑制剂。

3.If STI571 inhibits the BCR-ABL kinase so effectively, what is the result of its inhibition of the ABL kinase in normal cells?如果STI571可高效地抑制BCR-ABL激酶活性，那它对正常细胞的ABL激酶的抑制会产生什么结果呢？

4.What are the functions of the pre-BCR and pre-TCR in lymphocyte differentiation and antigen-receptor allelic exclusion?有哪些职能预导BCR和前T细胞受体淋巴细胞分化和抗原受体等位基因排斥？

5.But Gleevac, too, can be bypassed by further mutations of BCR-ABL which allow the tumour cells to grow in the presence of the drug.但它无法阻止BCR-ABL产生进一步变异后的编码蛋白，即使在用药情况下肿瘤细胞仍不断扩张。

6."Banks do not install ATMs in blocks of flats, " BCR spokesman Cornel Cojocaru said.该行发言人CornelCojocaru说：“银行不会在公寓街区单独安装ATM。”

7.Conclusion: BCR and SSEP were useful methods in diagnosis of the pudendal nerve with pathological changes in female patients with diabetes.结论：糖尿病患者存在阴部神经的损害，BCR和SSEP检测有助于诊断。

8.Methods: To read the related literatures then to review and comment the B lymphocyte development and BCR gene rearrangement.方法：通过相关文献的阅读，综合评述B细胞发育与BCR基因重排。

9.In BCR-ABL fusion gene negative myeloproliferative diseases, the discovery of JAK2V617F point mutation is an important landmark.在BCR-ABL阴性的骨髓增殖性疾病的发病机制中，JAK2V617F点突变的发现是一个重大的突破。

10.Inhibiting BCR-ABL tyrosine kinases can impede the growing progress of tumors.抑制BCR-ABL酪氨酸激酶可有效抑制肿瘤生长。